Patients with pre-surgery cognitive impairment cannot currently be assessed for cognitive recovery after surgery using the Postoperative Quality of Recovery Scale (PostopQRS), as they would mathematically be scored as recovered. We aimed to validate a novel method to score cognitive recovery in patients with low-baseline cognition, using the number of low-score tests rather than their numerical values. Face validity was demonstrated in 86 participants in whom both the Postoperative Quality of Recovery Scale and an 11-item neuropsychological battery were performed. The Postoperative Quality of Recovery Scale agreed with neuropsychological categorisation of low vs. normal cognition 74% of the time, with all but five incorrectly coded participants deviating by only one neurocognitive test. Cognitive recovery over time was comparable for groups with differing baseline cognitive function, irrespective of whether the Postoperative Quality of Recovery Scale or neuropsychological methods were used. Discriminant validation was demonstrated in a post-hoc analysis of the steroids in cardiac surgery substudy by allocating groups to normal (n = 246) or low-baseline cognition (n = 231) stratified by cognitive recovery on day 1. Recovery was similar for participants with low and normal baseline cognition. Postoperative length of stay was longer in patients with failed cognitive recovery whether they had normal mean (SD) (10.4 (10.0) vs. 8.0 (5.9) days, p = 0.02) or low-baseline cognition (12.0 (11.1) vs. 8.2 (4.7) days, p < 0.01). Overall quality, as well as cognitive, emotive and physiological recovery was independent of baseline cognition. The modified scoring method for the Postoperative Quality of Recovery Scale cognitive domain demonstrates acceptable face and discriminant validity.
Introduction
Postoperative cognitive dysfunction (POCD) is associated with serious morbidity and mortality [1] [2] [3] [4] [5] . Cognitive decline is common after major surgery [6] [7] [8] [9] , particularly in the elderly [3, 8] , making cognitive recovery an important determinant of overall long-term surgical outcome.
Early detection of cognitive recovery may alert healthcare practitioners to the risk of poor overall recovery and, possibly, provide opportunity for early intervention. The Postoperative Quality of Recovery Scale (PostopQRS) is a multidimensional survey-based tool, which includes a domain designed to measure cognitive postoperative recovery over time [10] . The cognitive domain includes five verbal cognitive tests. The other domains are physiological, emotive, nociceptive and activities of daily living. The scale also includes an overall patient perspective domain.
The scale is determined pre-operatively to provide individual baseline measurements for each patient.
Thereafter, recovery in various domains is defined by postoperative values equalling or exceeding individual baseline values, except for the cognitive domain where a tolerance level is added to adjust for normal performance variability [11] . That is, patients can perform a little worse than baseline in the cognitive domain, by the magnitude of the tolerance factor, and still be scored as recovered. Currently, patients whose pre-operative performance is so low such that any postoperative performance will fall within the tolerance factor, are considered to have a low-baseline performance in that test. A consequence of having low-baseline cognition on a test preoperatively is that these patients will be automatically scored as 'recovered' when assessed postoperatively for these tests. Accordingly, participants with low-baseline cognition are not currently scored in the cognitive domain postoperatively, although they can be scored in other recovery domains. The difficulty is that patients with pre-existing cognitive impairment are at especially great risk of poor outcomes, especially if their cognition deteriorates [1, 2, 12] . To address this limitation of the PostopQRS, we developed a novel scoring method for cognitive recovery in patients with low-baseline scores in the cognitive domain. Specifically, we now consider the number of cognitive tests (out of five) on which a patient performs poorly pre-operatively (i.e. below the test's threshold value for low-baseline cognition). Postoperative recovery in this population is then defined as the same number of tests or fewer that score below the threshold value. If more tests score below the threshold values than seen pre-operatively, then cognitive recovery has not occurred. Our aim was to demonstrate both face and discriminant validity for this modified scoring method.
Methods
We used two existing datasets. The first was from a singlecentre observational study entitled 'Comparison of neurocognitive assessment vs. PostopQRS cognitive domain performance to assess cognitive recovery in patients undergoing cardiac surgery', conducted at the Royal Melbourne Hospital, Australia. It included 69 patients undergoing cardiac surgery, each of whom had both PostopQRS and a comprehensive neurocognitive test battery. The second was from the quality of recovery substudy of the steroids In cardiac surgery (SIRS) trial [13] . All participants understood and spoke English well enough to complete the testing surveys, and none had known psychiatric disease, dementia or any medical or learning disorder that would impair cognitive ability.
In each study, patients were assessed pre-operatively and at multiple postoperative times. We compared cognitive recovery in patients who had normal or low cognitive baseline and determined whether clinical outcomes (quality of patient recovery, length of stay, cardiovascular complications, surgical complications and death) differed for participants who did and did not demonstrate cognitive recovery on the first postoperative day.
The cognitive domain of the PostopQRS consists of five verbal cognitive tests: orientation, digits forward, digits back, word recall and word generation. Cognition is deemed recovered when scores on all five tests return to within a small delta ('tolerance factor') of baseline values. The tolerance factors for the cognitive subdomains are 0/3 for orientation, 2/6 for digits forward, 1/6 for digits back and 3/15 for word recall, and 3/unlimited for word generation [11] . Since patients whose initial cognitive performance on any test is less than the allowed tolerance are automatically scored as recovered postoperatively with the original scoring approach, we modified our scoring system for patients whose pre-operative cognitive function was poor, with poor being defined by an initial score within the tolerance range on any of the five cognitive tests. Specifically, the modified system considers the number of cognitive tests on which patients scores below the tolerance range pre-operatively. Patients are then considered recovered postoperatively when they score poorly on no more tests than they did pre-operatively. For example, a patient who had one low-baseline cognitive test pre-operatively will be scored as recovered if they perform poorly on no more than any one of the five cognitive tests postoperatively, but not if they have low performance on two or more of the tests.
We determined face validity by comparing low vs. normal baseline patients using an 11-item neurocognitive battery as the reference method. Face validity was considered to have been established if cognitive recovery was similar for low and normal baseline cohorts using each method. The PostopQRS and the neuropsychological battery tests were performed by trained research staff.
The PostopQRS interviews were conducted face-to-face while patients were hospitalised or via telephone after discharge (11 Table S1 . To investigate discriminant validation [13] , we hypothesised that the quality of recovery as well as clinical outcomes (length of stay, cardiovascular complications, surgical complications and death) would be worse in patients who failed to recover early (day 1) in the cognitive domain, compared with those patients who did have early cognitive recovery, independent of whether they had low or normal baseline cognitive function. This substudy was part of the steroids in SIRS trial [19] . The substudy started well after the underlying trial began, and was restricted to the Royal Melbourne Hospital (Australia), the Cleveland Clinic (USA) and the Hamilton Health Sciences and McMaster University (Canada).
Amendments to the SIRS ethics approvals and local governance approvals were obtained at each participating centre to conduct this substudy.
A detailed description of the underlying SIRS trial has been published [19] . In brief, it was a double-blind, placebo-controlled, randomised, multi-centre trial on high-risk patients undergoing cardiac surgery (Euro-SCORE ≥6). The intervention was to administer 250 mg of methylprednisolone at anaesthetic induction and a further 250 mg just before commencement of cardiopulmonary bypass. The PostopQRS was conducted within two weeks before surgery (baseline) and one day, two days, three days, one month and six months after surgery. The physiological subdomain was only measured on postoperative days 1-3. The results of the comparison between methylprednisolone and placebo have been previously reported and showed no difference between groups [20] . In this analysis, the participants were, therefore, combined.
Cognitive recovery was scored using the current method for participants with normal baseline scores and using the modified scoring system for participants with low-baseline scores (see above). Two groups were 
Results
Sixty-nine participants were enrolled, but two were not studied due to incomplete data. Eighteen participants (27%) had low-baseline PostopQRS cognition. Baseline characteristics and operative data are shown in Table S2 .
For each participant, the number of tests that were Baseline characteristics and operative details for normal and low-baseline cognition groups are shown in Table S3 . Mean (SD) ages were 72 (12) years in the cognitively recovered group, and 72 (11) years in the nonrecovered group. Generally, the cognitively recovered and non-recovered participants were similar, although there was a tendency towards a higher proportion of active smokers among the non-recovered participants.
The normal and the low-baseline groups were similar except the tendency towards higher age in the lowbaseline group.
A comparison of recovery in all domains of the PostopQRS, using the modified scoring system for lowbaseline cognition, is shown for all participants with normal and low-baseline cognition in Figure S2 . The lowbaseline group had slightly better cognitive recovery, but with a similar profile across time to the patients with normal baseline cognition. Recovery profiles did not differ significantly in any other domains.
Clinical outcomes of participants with normal cognitive baseline scores are displayed in Table 1 There were no differences between groups in any of the other outcomes.
Quality of recovery over time to six months after surgery in normal baseline cognition participants is shown for cognitively recovered vs. not recovered groups in Fig. 4 .
The incidence of overall recovery was higher for recovered compared with non-recovered participants, p < 0.01. The cognitive and physiological domains showed better recovery for the recovered group (p < 0.01), but not emotive, nociceptive or functional recovery.
Clinical outcomes for participants with low-baseline cognitive scores are shown in Table 2 . Total length of stay was shorter in the cognitively recovered group Figure 2 The proportion of participants who recovered in the PostopQRS cognitive domain is shown over time for participants with low and normal baseline cognition. Low-baseline cognition is categorised by both PostopQRS and neuropsychological definitions. Figure 3 The proportion of participants who recovered using neuropsychological criteria is shown over time for participants with low and normal baseline cognition. Low-baseline cognition is categorised by both PostopQRS and neuropsychological definitions.
Quality of recovery over time for patients with low cognitive baseline scores is illustrated in Fig. 5 . Overall recovery was higher in the recovered group (p < 0.01).
Cognitive, physiological and emotive recovery was higher in the recovered group (all p < 0.01), whereas there were no differences between the groups in terms of nociception or activity of daily living.
Recovery profiles for participants with normal cognitive baseline scores based on the number of tests where recovery had failed, are shown in Figure S3 and participants with low cognitive baseline scores are displayed in Figure S4 . Generally, recovery was worse in patients with poor baseline cognitive function, especially in the cognitive, physiological and overall recovery domains.
Discussion
Face validity implies that the test responds as expected and includes construct validity where tests measuring similar constructs should produce similar results [21] . The PostopQRS agreed with neuropsychological categorisation of low vs. normal baseline cognition in most participants. Importantly, where disagreement occurred, it was usually by a small margin on one test on the neuropsychological battery. This is unsurprising, as PostopQRS cognitive tests are derivatives of the neuropsychological battery, with a focus on brief, verbal tests designed to facilitate telephone use [11] . The 11-item battery includes visuospatial and motor tests in addition to the verbal tests, and although they essentially measure similar constructs, the motor tests assess cognitive performance in areas that the PostopQRS does not.
Most participants with normal baseline PostopQRS but low-baseline neuropsychological cognition failed at least one motor test, whereas the majority of low-baseline PostopQRS/normal baseline neuropsychological participants failed a single verbal test. It is of note that motor tests Status of recovery refers to the cognitive subdomain on the first postoperative day, and renal function is defined according to the RIFLE criteria. Odds ratios and confidence intervals are calculated as superiority of cognitive recovery to cognitive non-recovery at first postoperative day, that is, an OR of more than 1 indicates superiority of recovery, whereas an OR of less than 1 indicates superiority of non-recovery.
are not included in the PostopQRS Cognitive subtests. We demonstrated further face validity by showing that cognitive recovery was similar for both low and normal baseline cohorts, whether or not PostopQRS or neurocognitive methods were used to categorise low-baseline cognition. We included a reverse analysis, and showed face validity that a neurocognitive definition of recovery was comparable in normal-and low-baseline participants, irrespective of the method used to categorise low-baseline.
Recovery improved over time in both normal and low-baseline groups in a manner that is consistent with previous data [10, 11, [22] [23] [24] [25] , indicating that the new scoring system produces similar results in low-baseline participants to the normal baseline participants. This similarity of cognitive recovery between groups that have normal vs. low-baseline cognition has potentially important clinical implications given the current debate regarding the relationship between pre-existing cognitive impairment and poor postoperative cognitive function [1, 3, 6, [26] [27] [28] , and emphasises the need to validate a scoring system with which to measure cognitive recovery in those patients with a low pre-operative baseline.
We demonstrated discriminant validity for the modified scoring system using the SIRS trial substudy data Figure 4 Recovery over time is shown for the SIRS substudy cohort in participants with normal baseline cognition, categorised by the presence or absence of cognitive recovery on day 1 after surgery. *p < 0.05. [13] . Quality of recovery in the SIRS trial was similar in normal and low-baseline participants for domains other than cognition (which could previously not be scored for the low-baseline group). However, when the modified cognitive scoring was applied to the low-baseline participants, and groups were allocated according to cognitive recovery on day 1, then the differences in clinical and quality of recovery outcomes in both low and normal baseline groups were similar, favouring early cognitive recovery. Discriminant validity was further demonstrated by a pattern of increasingly worse recovery as the number of tests failed at baseline increased, indicating a severity effect.
Our primary aim was to validate a new scoring method for cognitive recovery in patients with low-baseline cognition. The cohort study comparing PostopQRS and the neuropsychological test was sufficient to demonstrate face validity, but too small to evaluate clinical outcomes. In the clinical trial, we allocated groups according to cognitive recovery on day 1 and, hence, only participants who completed the PostopQRS at day 1 were included in these analyses. It is possible that participants who declined to complete the assessment at this timepoint had a worse outcome introducing a potential inclusion bias. The sample size in this substudy was determined by the number of participants assessed with the PostopQRS in the SIRS study, and it was not a priori powered for the post-hoc analysis to detect potential differences between low and normal cognitive baseline scores. Comparison of these groups was used to test for discriminant validation of the proposed scoring system for low-baseline patients, rather than to assess the importance of early cognitive recovery, and we urge caution in further analysis of these data. However, whether early detection of cognitive Status of recovery refers to the cognitive subdomain on the first postoperative day, and renal function is defined according to the RIFLE criteria. Odds ratios and confidence intervals are calculated as superiority of cognitive recovery to cognitive non-recovery at first postoperative day, that is, an OR of more than 1 indicates superiority of recovery, whereas an OR of less than 1 indicates superiority of non-recovery. Data reported as means AE standard deviations or absolute numbers and percentages of patients. -, OR cannot be calculated due to low number of events. *p <0.05.
failure provides a window-of-opportunity for interventions that might improve outcomes, merits further research. 
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